VSee Health Shareholders Approve Major Warrant-Linked Equity Issuance

The latest update is out from VSee Health ( (VSEE) ).

On March 2, 2026, VSee Health, Inc. held a special meeting of stockholders at which 50.46% of the company’s outstanding voting capital stock was represented, satisfying quorum requirements under its amended bylaws. Stockholders considered two proposals related to a private placement transaction and the potential adjournment of the meeting to secure additional votes if needed.

Stockholders approved, under Nasdaq Listing Rule 5635(d), the issuance of shares of common stock to certain holders of warrants to purchase up to 19,672,130 shares, thereby authorizing a significant equity issuance tied to existing warrant holders. They also approved an adjournment proposal in case further solicitation became necessary, but this measure was ultimately withdrawn because the private placement proposal received sufficient support in the initial vote.

The most recent analyst rating on (VSEE) stock is a Sell with a $0.33 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.

Spark’s Take on VSEE Stock

According to Spark, TipRanks’ AI Analyst, VSEE is a Underperform.

The score is driven primarily by weak financial performance (losses, negative operating cash flow, and negative equity) and bearish technicals (price below key moving averages with negative MACD). Valuation offers limited support due to negative earnings and no dividend, while recent corporate actions provide only a small offset.

To see Spark’s full report on VSEE stock, click here.

More about VSee Health

VSee Health, Inc. is a Delaware corporation whose shares of common stock are listed on the Nasdaq Stock Market. The company has both common stock and Series A preferred stock outstanding, with its capital structure giving voting rights to holders of each class in stockholder meetings.

Average Trading Volume: 801,011

Technical Sentiment Signal: Sell

Current Market Cap: $15.27M

For a thorough assessment of VSEE stock, go to TipRanks’ Stock Analysis page.